Results 71 to 80 of about 109,191 (186)

Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types

Pathology International, Volume 75, Issue 6, Page 291-309, June 2025.
We propose a new rare cancer classification system using the updated International Classification of Diseases for Oncology 3.2 coding system and the World Health Organization Classification of Tumors 5th edition. This list could serve as a diagnostic classifier to reliably distinguish various rare cancers for clinical applications.
Ryoko Rikitake, Yasushi Yatabe, Yoko Yamamoto, Tatsunori Shimoi, Shintaro Iwata, Yasushi Goto, Yu Mizushima, Akira Kawai, Takahiro Higashi   +8 more
wiley   +1 more source

Landscape of TET2 Mutations: From Hematological Malignancies to Solid Tumors

Cancer Medicine, Volume 14, Issue 6, March 2025.
Somatic TET2 mutations are reported in numerous solid human cancers, including those arising in the skin, lung, and prostate, although there is a paucity of data on their frequency in these settings compared to hematological malignancies. TET2 mutations affect prognosis in myeloid leukemia and other hematopoietic malignancies, but little is known about
Zoë L. Hawking, James M. Allan
wiley   +1 more source

Mullerian Adenosarcoma of Uterus with Sarcomatous Overgrowth and Heterologous Component Associated with Stromal Deposit in Omentum: A Case Report and Review of the Literature

Case Reports in Medicine, 2012
Background. Mullerian adenosarcoma with sarcomatous overgrowth (MASO) is a very rare variant of uterine sarcomas first described by Clement et al. as early as 1974.
Anuradha Sinha, Jyoti Prakash Phukan, Sanjay Sengupta, Paulami Guha   +3 more
doaj   +1 more source

HETEROTOPIC CARTILAGE IN THE MYOMETRIUM

Gomal Journal of Medical Sciences, 2018
We describe a rare case of chondroid heterotopia in the myometrium with associated foci of adenomyosis, in a 45 years old female, presenting with abnormal uterine bleeding and abdominal pain.
Rubina Gulzar, Ruqaiya Shahid, Omema Saleem, Shazia Mumtaz, Yusra Memon   +4 more
doaj   +1 more source

Nanomedicine for cancer patient‐centered care

MedComm, Volume 5, Issue 11, November 2024.
Nanomedicine can satisfy the need for developing precision oncology, promote modern early diagnostic systems, monitoring the therapy based on the response of the individual patient, and provide precision antitumor immunotherapy and gene therapy, which can be developed with sophisticated experiments such as those made with organ‐on‐chip technology ...
Carlo Sorrentino, Stefania Livia Ciummo, Cristiano Fieni, Emma Di Carlo   +3 more
wiley   +1 more source

Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas [PDF]

International Journal of Gynecological Cancer, 2018
This study aimed to identify the hormonal receptor status in uterine adenosarcoma (AS) and uterine AS with sarcomatous overgrowth (AS + SO), including those with high-grade histologic features (nuclear pleomorphism, atypical mitoses, necrosis), with or without heterologous elements.
Jenna Z, Marcus, Merieme, Klobocista, Rouzan G, Karabakhtsian, Eric, Prossnitz, Gary L, Goldberg, Gloria S, Huang   +5 more
openaire   +2 more sources

Polypoid endometriosis—An exceptional subtype of endometriosis mimicking an aggressive pelvic cancer

Clinical Case Reports, Volume 12, Issue 9, September 2024.
Key Clinical Message Polypoid endometriosis is a rare manifestation of endometriosis, which may mimic pelvic cancer. This subtype commonly encountered in post‐menopausal women may be wrongly mistaken for a neoplasm on clinical, radiological, perioperative or pathologic assessments leading to inadequate treatment.
Katia Mahiou, Fara Tanjona Harizay, Morgane Lanouziere, Olivia Martz, Laurence Filipuzzi, Jean‐Marc Rousselet, Laurent Martin, Laurent Arnould, Mathilde Funes De La Vega, Anthony Bergeron   +9 more
wiley   +1 more source

Uterine adenosarcoma associated to lymphovascular emboli: a case report [PDF]

Cases Journal, 2009
Abstract Introduction Uterine adenosarcoma is a rarely observed polypoid tumor with a mixed benign epithelial element and malignant stromal component. The treatment is total hysterectomy with bilateral salpingo-oophorectomy. It could be difficult to diagnose and associated to lymphovascular invasion.
Sakr, Rita, Marzouk, Paul, Bricou, Alexandre, Demaria, Fabien, Cortez, Annie, Benifla, Jean-Louis   +5 more
openaire   +2 more sources

Rare Mullerian adenosarcoma of the uterine cervix arising on a background of endometriosis: A diagnostic challenge with risk of malignant transformation—A case report and review of the current literature

Clinical Case Reports, Volume 12, Issue 6, June 2024.
Key Clinical Message Endometriosis may contribute to Mullerian adenosarcoma development but makes diagnosis challenging given similar symptoms. Survival benefit has not been definitively shown for chemotherapy, hormonal therapy, or radiotherapy, consolidating surgery as the mainstay treatment.
Hannah Bruguier, Natalie Maalouf, Sarah Louise Smyth, Stephen Damato, Priyanka Reddy, Hooman Soleymani majd   +5 more
wiley   +1 more source

Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy [PDF]

, 2008
Introduction: Asoprisnil, a novel orally active selective progesterone receptor modulator, is being studied for the management of symptomatic uterine leiomyomata. The exact mechanism of action is not yet discerned.
Williams, A.R.W., Chwalisz, K., Hapangama, D., Critchley, Hilary O.D., Wilkens, Julia, Walker, Jane, Lawrence, A.C., Williams, Alistair R.W., Lumsden, M.A., Lawrence, Alexandra C., Ingamells, S., Chwalisz, Kristof, Hapangama, Dharani, Critchley, H.O.D., Han, Cong, Ingamells, Susan, Wilkens, J., Cameron, I.T., Cameron, Iain T., Lumsden, Mary Ann, Han, C., Walker, J.   +21 more
core   +1 more source